uveitis

Wall Street IPO initial public offering markets shares stock
Biotech

Alumis downsizes IPO, tacks on private placement

In the latest sign that biotech’s return to the public markets remains somewhat lackluster, Alumis has downsized its IPO.
James Waldron Jun 28, 2024 5:02am
Photo of Wall Street street sign with american flags in the background

Alumis eyes $300M IPO to fund clinical-stage TYK2 pipeline

Jun 24, 2024 8:14am
Graphic image of the letters IPO in white in front of a yellow background

Alumis plans IPO to fund TYK2 inhibitor through phase 3 trials

Jun 10, 2024 8:35am
long shot miss basketball hoop fail shoot

Roivant ends longshot lupus program after phase 2 fail

Nov 27, 2023 9:48am
Nasdaq

Acelyrin eyes IPO boost to $400M haul to take on Lilly, Novartis

Apr 14, 2023 6:10am